The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

Share Price Information for Mobeus I&g (MIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 54.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.505%)
Open: 56.00
High: 56.00
Low: 56.00
Prev. Close: 56.00
MIX Live PriceLast checked at -
Mobeus Income & Growth VCT is an Investment Trust

To provide investors with a regular income stream, by way of tax-free dividends, generated from income and capital returns, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement 3rd Quarter Results

6 Nov 2018 15:42

RNS Number : 5339G
Mobeus Income & Growth VCT PLC
06 November 2018
 

Mobeus Income & Growth VCT plc

("the Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2018

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the third quarter ended 30 September 2018. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE (NAV) AND TOTAL RETURN PER SHARE

At 30 September 2018

At 30 June 2018

Net assets attributable to shareholders

£74.18 million

£75.38 million

Shares in issue

107,696,072

108,170,944

Net asset value (NAV) per share

68.88 pence

69.69 pence

Cumulative dividends paid

113.80 pence

111.80 pence

Cumulative total return per share (NAV basis) since inception in 2004

182.68 pence

181.49 pence

 

The NAV per share decreased by 0.81 pence over the quarter, principally due to the payment of an interim dividend of 2.00 pence per share in the quarter, referred to below.

 

DIVIDENDS

The Company paid an interim capital dividend of 2.00 pence per share for the year ending 31 December 2018 on 21 September 2018. This brings cumulative dividends paid since the launch of the Company to 113.80 pence per share.

 

INVESTMENT ACTIVITY

 

Investments during the period

The Company made one new investment and one follow-on investment into an existing portfolio company during the period.

 

On 13 August 2018, £0.57 million was invested into Rotageek, a provider of cloud-based enterprise software used to schedule staff effectively and fairly.

 

On 28 September 2018, a follow-on investment of £1.20 million was made into Preservica, a seller of proprietary digital archiving software.

 

Investments following the period end

On 9 October 2018, £0.83 million was invested into Biosite, an existing portfolio company and provider of workforce management and security services.

 

On 10 October 2018, a follow-on investment of £0.42 million was made into Proactive Investors, a provider of investor media services.

 

On 19 October 2018, a follow-on investment of £0.07 million was made into MPB, an online marketplace for used photographic equipment.

 

Realisations during the period

On 28 August 2018, the Company realised its investment in Fullfield, receiving cash proceeds of £0.92 million. The realisation contributed to a return of 1.2 times the original investment cost, and an IRR of 5.0% over the seven years that this investment was held.

 

On 7 September 2018, £0.27 million cash proceeds was received from the sale of Hemmels Limited, a restorer of classic cars. The sale represented a realised loss of £0.33 million on the original investment cost over the six months this investment was held.

 

On 18 September 2018, the Company realised its investment in Lightworks, receiving cash proceeds of £0.94 million. The realisation contributed to a return of 21.7 times the original investment cost and an IRR of 57.2%.

 

Including the preference share repayments of £0.09 million referred to below, and liquidation proceeds of £0.02 million, net cash proceeds for the period amounted to £2.24 million.

 

PREFERENCE SHARE REPAYMENTS

The Plastic Surgeon Holdings bought back a total of £0.18 million of A preference shares owned by the Company, in two equal tranches on 31 July and 31 October 2018.

 

SHARE BUY-BACKS

On 17 August 2018, the Company purchased 195,000 of its own ordinary shares at a price of 61.50 pence per share for cancellation. On 26 September 2018, the Company purchased a further 279,872 of its own ordinary shares at an average price of 60.50 pence per share for cancellation.

 

Following these purchases, the Company has 107,696,072 ordinary shares of 1 penny each in issue.

 

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

 

Robert King, for Mobeus Equity Partners LLP, Company Secretary

020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTFSEFIMFASEDF
Date   Source Headline
31st Mar 20217:00 amRNSAnnual Financial Report for 31 December 2020
26th Mar 20219:00 amRNSINVESTEE COMPANY – INTENTION TO FLOAT
2nd Mar 20219:00 amRNSUnaudited NAV & Admission to AIM of Virgin Wines
25th Feb 20219:30 amRNSInvestee Company - Intention to Float
12th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Dec 202010:19 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20203:05 pmRNSDirector Declaration
1st Dec 20203:00 pmRNSRealisation of Investment
17th Nov 20203:22 pmRNSInterim Management Statement - 3rd Quarter
21st Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20204:15 pmRNSTransaction in Own Shares
11th Sep 20203:30 pmRNSHalf-year Report
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
2nd Jul 20209:16 amRNSTransaction in Own Shares
14th May 20202:30 pmRNS1st Quarter Results
12th May 20203:45 pmRNSResult of AGM
29th Apr 20201:00 pmRNSRevised Annual General Meeting Arrangements
15th Apr 202011:00 amRNSTransaction in Own Shares
7th Apr 20207:48 amRNSAnnual Financial Report
2nd Apr 20205:10 pmRNSIssue of Equity
2nd Apr 202010:00 amRNSDividend Declaration
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
19th Mar 202012:00 pmRNSDirector Declaration - Non-Executive Appointment
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
3rd Feb 202011:30 amRNSTotal Voting Rights
8th Jan 20204:31 pmRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
13th Dec 20195:50 pmRNSDividend Declaration
12th Dec 201912:40 pmRNSTransaction in Own Shares
19th Nov 201912:00 pmRNSFundraising Update
6th Nov 20195:20 pmRNS3rd Quarter Results
6th Nov 20195:00 pmRNSDividend Declaration
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201912:20 pmRNSTotal Voting Rights - Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.